Madrigal Pharmaceuticals' IPO

Madrigal Pharmaceuticals raised a round of funding on February 06, 2007. Investors include Public.

Madrigal Pharmaceuticals (Nasdaq: MGDL), formerly Synta Pharmaceuticals, is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathw…

Articles about Madrigal Pharmaceuticals' IPO: